A detailed history of Alta Advisers LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Alta Advisers LTD holds 6,750 shares of BMY stock, worth $363,825. This represents 0.24% of its overall portfolio holdings.

Number of Shares
6,750
Previous 5,500 22.73%
Holding current value
$363,825
Previous $284,000 34.15%
% of portfolio
0.24%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$51.92 - $59.94 $64,900 - $74,925
1,250 Added 22.73%
6,750 $381,000
Q3 2022

Oct 28, 2022

BUY
$0.13 - $76.84 $715 - $422,620
5,500 New
5,500 $391,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Alta Advisers LTD Portfolio

Follow Alta Advisers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alta Advisers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Alta Advisers LTD with notifications on news.